trial · primary record
GN001
Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 42 |
| Primary completion | 2029-08 |
| Primary endpoint | Incidence of dose-limiting toxicities (DLTs) |
| Registry ID | NCT07910708 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:42:50.784Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07910708
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.